This topic contains a solution. Click here to go to the answer

Author Question: Jeong's uncompensated demand for gizmos is given by Q = 30 - 2p. Jeong's marginal willingness to pay ... (Read 56 times)

Bernana

  • Hero Member
  • *****
  • Posts: 530
Jeong's uncompensated demand for gizmos is given by Q = 30 - 2p. Jeong's marginal willingness to pay function is
 
  A) 30-2p.
  B) 15-.5Q.
  C) 30-2Q.
  D) -2.

Question 2

According to the cost-benefit principle if a change generates 50,000 in gains and 45,000 in losses,
 
  A) it is desirable.
  B) the gain is not large enough to justify the change.
  C) the desirability depends on who gains and who loses.
  D) it is a Pareto improvement.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Ksh22

  • Sr. Member
  • ****
  • Posts: 297
Answer to Question 1

B

Answer to Question 2

A




Bernana

  • Member
  • Posts: 530
Reply 2 on: Jul 1, 2018
:D TYSM


matt95

  • Member
  • Posts: 317
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Drug abusers experience the following scenario: The pleasure given by their drug (or drugs) of choice is so strong that it is difficult to eradicate even after years of staying away from the substances involved. Certain triggers may cause a drug abuser to relapse. Research shows that long-term drug abuse results in significant changes in brain function that persist long after an individual stops using drugs. It is most important to realize that the same is true of not just illegal substances but alcohol and tobacco as well.

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

The horizontal fraction bar was introduced by the Arabs.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library